Background: Approximately 50% of patients with inflammatory arthritis (IA) experience worsening disease activity during pregnancy. 1,2 Given the evidence that increased immediately before or pregnancy is associated adverse outcomes, it imperative to maintain tighter control this period. 3 Treatment options are limited steroids disease-modifying anti-rheumatic drugs (DMARDs) compatible Certolizu...